Myrobalan Therapeutics Holding
Medford, US · Founded 2023 · Delaware corporation
Founders & leadership
GF
Guoping FengNamed on SEC filing
MY
Minmin YangNamed on SEC filing
ZH
Zhigang HeNamed on SEC filing
JY
Jing Yu WangNamed on SEC filing
SY
Shixiang YanNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$24M disclosed across 1 round · 2024
▶$24MraisedJan 2024 · 12 investors · BiotechnologyRule 506(b)
▶$24MraisedJan 2024 · 12 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Guoping FengDirector
- Minmin YangDirector
- Zhigang HeDirector
- Jing Yu WangExecutive Officer, Director
- Shixiang YanDirector
- Offering amount
- $24M
- Amount sold
- $24M
- First sale
- Jan 2024
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Myrobalan Therapeutics Holding raised?
- Myrobalan Therapeutics Holding has disclosed $24M raised across 1 round.
- Where is Myrobalan Therapeutics Holding headquartered?
- Myrobalan Therapeutics Holding is headquartered in Medford, US.